[Clinical evaluation of De-Nol].
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009942:Organometallic Compounds; D010437:Peptic Ulcer / Q000188:drug therapy*; D014945:Wound Healing / Q000187:drug effects
D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate; D001729:Bismuth
Ocena kliniczna preparatu De-Nol.